This study shows multiple sclerosis (MS) costs over $3 billion annually, driven by rising prevalence. MS is a chronic, incurable neurological disease that imposes growing social and economic burdens. The report provides recommendations for government with a focus on improving care, access and research.

Adverse events during hospital care are a global concern. The evidence for addressing unsafe acute care using pay-for-performance is inconclusive. This research examined the association between the introduction of a financial penalty introduced by Australian policy in July 2018 and the prevalence of 13 high-priority hospital-acquired complications in Australian public hospitals.

This paper argues that Australian governments should consider an effective and proportionate value-based response to COVID-19, and its longer-term health consequences, that considers patient health outcomes and costs.